Medicine
Medroxyprogesterone 5 mg tablet
Medroxyprogesterone 5 mg tablet is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature 20° to 25°C (68° to 77°F). "Keep out of…
Key facts
- Active ingredient (INN)
- Medroxyprogesterone
- Brand
- Sold under the generic name
- Strength
- 5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 500 tablets and 6 more
- Manufacturers
- Mylan PharmaceuticalsPreferred PharmaceuticalsTeva PharmaceuticalsA-S Medication SolutionsBryant Ranch PrepackRemedyrepack
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature 20° to 25°C (68° to 77°F). "Keep out of reach of children"
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G03AC06 Medroxyprogesterone
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 December 1996
- Identifiers
- RxCUI 1000114, 1000135, 1000141DailyMed set ID 2627eb11-06bf-4a45-9172-094468e3ca07, bfdf335d-1cbb-4533-9fde-99a9c71f7504, a9e05272-aa4e-4df8-b08b-481abca3e8fd +3NDC 59762-0058, 50090-0491, 68788-8112 +3Application NDA011839, ANDA040159
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 59762-0058-1 | Mylan Pharmaceuticals | 2 January 2019 |
| 1000 tablet in 1 bottle | 59762-0058-2 | Mylan Pharmaceuticals | 11 May 2020 |
| 100 tablet in 1 bottle | 0555-0873-02 | Teva Pharmaceuticals | 4 December 1996 |
| 500 tablet in 1 bottle | 0555-0873-04 | Teva Pharmaceuticals | 4 December 1996 |
| 30 tablet in 1 bottle | 50090-0491-1 | A-S Medication Solutions | 29 June 2016 |
| 100 tablet in 1 bottle | 63629-8826-1 | Bryant Ranch Prepack | 4 December 1996 |
| 10 tablet in 1 bottle | 68788-8112-1 | Preferred Pharmaceuticals | 6 December 2021 |
| 30 tablet in 1 bottle | 68788-8112-3 | Preferred Pharmaceuticals | 6 December 2021 |
| 100 pouch in 1 box / 1 tablet in 1 pouch | 70518-4777-0 | Remedyrepack | 17 October 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 June 1959 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Medroxyprogesterone 5 mg tablet.
Other strengths and forms of Medroxyprogesterone
Clinical summary
Medroxyprogesterone is a progestin indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. MedsAcross supplies Medroxyprogesterone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MedroxyprogesteroneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Provera prescribing information (Pharmacia & Upjohn) · U.S. National Library of Medicine, DailyMed
Need Medroxyprogesterone 5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.